Synthetic peptide corresponding to Human PP2A alpha + beta aa 297-309 (C terminal).
Our Abpromise guarantee covers the use of ab1309 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||Use a concentration of 0.5 - 2 µg/ml. Predicted molecular weight: 37 kDa.Can be blocked with Human PP2A alpha + beta peptide (ab22802).|
Primary incubated for 1 hour.
ab1309 has not yet been referenced specifically in any publications.